Where RCM automation ends and human judgment begins
Artificial intelligence can provide support in revenue cycle processes, but the best return comes from augmenting human judgment.
Healthcare organizations long have wanted to automate revenue cycle management (RCM) from end to end.
Unfortunately, despite expansive advances in artificial intelligence, automation and analytics, RCM leaders are generally reaching a similar conclusion – fully autonomous RCM processing remains elusive. However, that doesn’t mean that AI and automation don’t have a place.
RCM primarily depends on U.S. healthcare billing, which involves complex clinical judgment, uncertainty, regulatory nuance and context. It’s a qualitative system that’s shaped by payer behavior, ambiguity and regulatory interpretation.
In this environment, automation alone cannot deliver defensible, predictable revenue. AI still has a role, but for RCM, it works best as augmentation that supports human judgment where it matters most rather than as an autonomous technology.
Organizations need a realistic, streamlined roadmap for AI augmentation of RCM, one that reflects how high‑performing organizations are deploying AI today for RCM.
RCM is a judgment system
Revenue cycle workflows may appear linear on paper, but in practice, they’re uncertain and challenging.
The same claim can be handled differently depending on the context. It may be paid by one payer, denied by another and partially reimbursed by a third. The different results may be related to subjective reasons tied to medical necessity interpretation, documentation framing or contract nuance.
This is why automation without human oversight consistently fails in RCM. Regulators, auditors and payers don’t accept what an AI model may have decided regarding justification for payment outcomes.
Accountability ultimately remains with humans. As a result, the goal for using AI in RCM is not to replace judgment, but to scale it responsibly.
Phase 1: Automate the deterministic core
Most organizations begin their automation journey in the safest, most predictable place – high-volume, rules-based tasks where variability is low and outcomes are clear. This is where automation delivers immediate value without introducing meaningful compliance risk.
Possible applications here include eligibility checks, demographic validation, payment posting and standard claim submission workflows. These are areas in which payer logic is relatively stable and decisions don’t hinge on clinical nuance.
In practice, this phase is less about innovation and more about discipline. High-performing teams focus on cleaning up front-end processes and removing manual friction from tasks that never required human judgement in the first place.
At the same time, they’re careful not to overreach. Functions like appeals, medical necessity decisions or contract interpretation may seem like natural candidates for automation, but they quickly break down without human oversight.
To succeed in this phase, organizations must use automation to create capacity and earn trust, not to replace accountability. That means freeing staff from repetitive work while keeping humans firmly in the loop for exceptions, quality assurance and monitoring shifts in payer behavior.
Phase 2: AI for prioritization and prediction
After the operational foundation is stable, AI begins to play a more strategic role by helping organizations decide where to focus.
In this phase, many healthcare leaders begin to see their first meaningful differentiation. Instead of treating all claims, accounts or denials equally, AI introduces a layer of intelligence that highlights what matters most.
For example, rather than working accounts receivable in chronological order, teams can prioritize high-value or high-risk claims or those claims that they believe are most likely to be collected. Instead of reacting to denials after they happen, they can identify patterns and intervene earlier. AI shifts the question from “What do we do next?” to “What should we be paying attention to first, and why?”
This is often where efficiency gains turn into financial impact. By directing human expertise toward the cases that truly require it, organizations reduce wasted effort and improve yield without increasing headcount.
AI doesn’t need to replace decision-making to be valuable; it just needs to sharpen it. Leaders should focus less on automation rates and more on whether their teams are spending time on the highest-impact work. If AI isn’t changing prioritization, it’s likely not delivering its full value.
Phase 3: Human decision augmentation
As capabilities mature, AI moves closer to the decision-making process itself, without replacing it. Instead, it acts as a copilot, helping staff navigate the complexity and subjectivity that define revenue cycle work. This is especially evident in areas like denials management, where outcomes often depend on how effectively a case is framed, documented and communicated.
In more advanced organizations, AI can draft appeal language, highlight missing documentation or explain why a denial is likely to occur in the first place. It can translate clinical details into payer-specific language or surface the evidence most likely to influence an outcome. However, the final decision – and the accountability that comes with it – remains firmly with humans.
This reflects the deeper reality that most RCM challenges aren’t technical problems, but judgment problems. While AI can accelerate and standardize aspects of that judgment, it can’t own it.
The goal for leadership is to make humans more effective within the process, which means investing in tools that enhance decision quality and consistency while also putting guardrails in place to ensure those decisions stand up to scrutiny.
Phase 4: Integrated, governed operations
At maturity, AI becomes part of the operational fabric. It connects workflows across eligibility, coding, denials and accounts receivable, creating a more unified and responsive revenue cycle. Insights generated in one area inform actions in another, and continuous feedback loops help systems improve over time.
What distinguishes leading organizations at this stage is how well they’ve governed it beyond how much they’ve automated. They recognize that complexity hasn’t disappeared; it’s simply been redistributed. As a result, they invest in new roles and capabilities focused on oversight, including automation auditing, compliance validation and exception management.
They also plan for failure. One emerging best practice is downtime readiness, ensuring that teams can still operate effectively if automation systems go offline, reflecting a broader understanding that resilience is critical in healthcare operations.
Success requires a shift in mindset by measuring how predictable and defensible revenue outcomes are instead of how much work is automated.
Organizations that reach this stage don’t chase autonomy; they build systems that balance intelligence with control.
Titus Leo is senior vice president for client services at Sagility, a tech-led, healthcare-focused business process optimization partner.